VIRX
VIRACTA THERAPEUTICS INC (VIRX)
$2.121.44%▲
Market is closedMarket is closed – opens on 8 PM, 30 Jan 2023
– opens on 8 PM, 30 Jan 2023
Key Stats
$2.03
Day's Range
$2.17
$1.21
52-Week Range
$5.75
| Returns % | |
| 1 month return | 68.25% |
| 3 month return | 46.06% |
| 1 year return | 20.9% |
| 5 year return | 86.5% |
Analyst Recommendation
based on 11 analysts ratings
Buy
90%
Buy
9%
Hold
0%
Sell
Based on 11 Wall street analysts offering stock ratings for VIRACTA THERAPEUTICS INC(by analysts ranked 0 to 5 stars)
Analyst Forecast
What analysts predicted
Upside of 607.55%Current
$2.12
Target
$15.0
Recommendation Trend
Based on 11 analyst
| Current | 1M Ago | 3M Ago | |
| Buy | 10 | 4 | 10 |
| Hold | 1 | 0 | 1 |
| Sell | 0 | 0 | 0 |
| Consensus | BUY | BUY | BUY |
Company Financials
Highlights
| Market Capitalization | 81.0M |
| Book Value | $1.65 |
| Dividend Share | 0.0 |
| Dividend Yield | 0.0% |
| Earnings Per Share (EPS) | 1.49 |
| PE Ratio | 1.42 |
| Wall Street Target Price | 15.0 |
Valuation
| Trailing PE | 1.42 |
| Forward PE | 0.0 |
| Price/Book (mrq) | 1.18 |
| Enterprise Value | 7.4M |
| Enterprise Value/Revenue | 0.0 |
| Enterprise Value/Ebitda | -0.15 |
Technicals
| 50 Day MA | 2.02 |
| 200 Day MA | 3.18 |
Institutional Holdings
Bvf Inc
9.46%
Citadel Advisors Llc
4.09%
Vanguard Group Inc
2.92%
Rubric Capital Management LP
2.6%
LAURION CAPITAL MANAGEMENT LP
1.83%
Samsara BioCapital, LLC
1.81%
Company Information
Viracta is a precision oncology company targeting virus-associated malignancies. The Company's proprietary investigational drug, nanatinostat, is currently being evaluated in combination with the antiviral agent valganciclovir as an oral combination therapy in a Phase 2 clinical trial for EBV-positive lymphomas. Viracta is pursuing application of this inducible synthetic lethality approach in other EBV-associated malignancies, such as nasopharyngeal carcinoma, gastric carcinoma, and other virus-related cancers.
| Organization | VIRACTA THERAPEUTICS INC |
| Employees | 33 |
| CEO | Mr. Daniel R. Chevallard |
| Industry | Healthcare |
Discover more
Frequently Asked Questions
What is VIRACTA THERAPEUTICS INC share price today?
Can Indians buy VIRACTA THERAPEUTICS INC shares?
How can I buy VIRACTA THERAPEUTICS INC shares from India?
Can Fractional shares of VIRACTA THERAPEUTICS INC be purchased?
What are the documents required to start investing in VIRACTA THERAPEUTICS INC stocks?
What are today’s High and Low prices of VIRACTA THERAPEUTICS INC?
What are today’s traded volumes of VIRACTA THERAPEUTICS INC?
What is today’s market capitalisation of VIRACTA THERAPEUTICS INC?
What is the 52 Week High and Low Range of VIRACTA THERAPEUTICS INC?
How much percentage VIRACTA THERAPEUTICS INC is down from its 52 Week High?
How much percentage VIRACTA THERAPEUTICS INC is up from its 52 Week low?
What are the historical returns of VIRACTA THERAPEUTICS INC?
Who is the Chief Executive Officer (CEO) of VIRACTA THERAPEUTICS INC?
Trading and brokerage services provided by
Banking and Remittance services provided by
Technology services provided by : Finzoomers Services Private Limited
Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*